RCT on T-REX Twente Regimen Effects on Quality of Life and Mobilisation for Cardiac Surgery Patients After Sternotomy
T-REX Twente
A Randomized Clinical Trial to Study the "T-REX Twente Regimen" (Thoracic Surgery Rehabilitation Experts Twente) on Quality of Life and Mobilisation Activities for Cardiac Surgery Patients After Median Sternotomy, Compared to Usual Care
3 other identifiers
interventional
154
1 country
1
Brief Summary
The goal of this study is whether the T-REX Twente precautions have a positive impact on the quality of life (MAcNew QLMI), level of physical activity, and reduction of fear of movement in heart patients after a total median sternotomy compared to the (current) standard precautions? Do these precautions also have no adverse effects on pain, wound healing, and/or postoperative complications? Participants will be instructed by the physiotherapist to both groups immediately postoperatively and are constantly repeated by the involved disciplines during the hospital stay. The control group is not allowed to lift, push, or pull for the first 6 weeks. There is little to no evidence for the current strict precautions currently implemented in the department. The intervention group receives the new T-REX Twente precautions, allowing for more independent activities through the use of the tube model (keeping elbows close to the sides). All patients receive three questionnaires (MacNew QLMI, Numeric Pain Rating Scale, and Tampa Scale for Kinesiophobia) preoperatively, on the 4th day postoperatively, on the first day of cardiac rehabilitation, and at the end of cardiac rehabilitation, taking approximately 10 minutes each time. Additionally, during the clinical admission immediately postoperatively, two AX3 accelerometers are placed on the patient, one lateroproximal on the right upper arm and one anterodistal on the right upper leg. Researchers will compare heart patients after a total median sternotomy with T-REX Twente precautions (intervention group) to the (current) standard precautions (control group).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 18, 2023
CompletedFirst Posted
Study publicly available on registry
November 3, 2023
CompletedStudy Start
First participant enrolled
May 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2026
CompletedFebruary 7, 2025
February 1, 2025
1.6 years
October 18, 2023
February 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Quality of Life after Myocardial Infarction Questionnaire (MacNew QLMI)
The first primary endpoint is the standardized response mean difference of Quality of Life after Myocardial Infarction Questionnaire (MacNew QLMI) pre-operative until the start of cardiac rehabilitation (4-6 weeks postoperatively). MacNew QLMI scores on a 7-pointscale (1-7), where 1 = always and 7 = never. MacNew QLMI is an ordinal scale, with a total sumscore of 189 points as the maximum quality of life.
Preoperative to start of cardiac rehabilitation (4-6 weeks postoperatively)
Not lying in bed
The second primary endpoint is the duration of not being in bed for up to 4 days in the ICU and the general ward, measured using two AX3 accelerometers.
Postoperative day 0 to postoperative day 4
Secondary Outcomes (5)
Numeric (Pain) Rating Scale (NPRS)
Preoperative to end of cardiac rehabilitation (12 weeks postoperatively)
Quality of Life after Myocardial Infarction Questionnaire (MacNew QLMI)
Preoperative to end of cardiac rehabilitation (12 weeks postoperatively)
Tampa Scale for Kinesiophobia (TSK)
Preoperative to end of cardiac rehabilitation (12 weeks postoperatively)
Individual mobilisation activities as measured with AX3 Accelerometer
Postoperative (directly after surgery, day 0) until hospital discharge (expected to be around postoperative day 5 to a maximum of 7 days)
Composite endpoint of sternal refixation, superficial and deep sternal wounds for 30 days after surgery
30-days postoperative
Study Arms (2)
T-REX Twente
EXPERIMENTALThe intervention group receives the new T-REX Twente precautions, allowing for more independent activities through the use of the tube model (keeping elbows close to the sides).
Usual care
ACTIVE COMPARATORThe control group is not allowed to lift, push, or pull for the first 6 weeks. There is little to no evidence for the current strict precautions currently implemented in the department.
Interventions
The intervention group receives the new T-REX Twente precautions, allowing for more independent activities through the use of the tube model (keeping elbows close to the sides).
The control group is not allowed to lift, push, or pull for the first 6 weeks. There is little to no evidence for the current strict precautions currently implemented in the department.
Eligibility Criteria
You may qualify if:
- Adult patients who are preoperatively included if they are undergoing a total median sternotomy at Thorax Centrum Twente (TCT)
- Patients with their treating cardiologist also working for TCT.
You may not qualify if:
- \>72 hours of admission to the Intensive Care Unit (ICU)
- Postoperative delirium (diagnosed with Diagnostic and Statistical Manual of Mental Disorders (DSM) version V
- Patients with dementia (or other significant cognitive disorders)
- Dutch language barriers
- Patients with a cardiologist from a location other than TCT
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medisch Spectrum Twentelead
- Foothills Medical Centrecollaborator
Study Sites (1)
Thoraxcentrum Twente
Enschede, Overijssel, 7500KA, Netherlands
Related Publications (4)
Benning MM, Kuo JM, Raushel FM, Holden HM. Three-dimensional structure of phosphotriesterase: an enzyme capable of detoxifying organophosphate nerve agents. Biochemistry. 1994 Dec 20;33(50):15001-7. doi: 10.1021/bi00254a008.
PMID: 7999757BACKGROUNDFloch HA. [Leprosy in Guadeloupe]. Bull Soc Pathol Exot Filiales. 1972 Jan-Feb;65(1):35-46. No abstract available. French.
PMID: 4677872BACKGROUNDPark L, Coltman C, Agren H, Colwell S, King-Shier KM. "In the tube" following sternotomy: A quasi-experimental study. Eur J Cardiovasc Nurs. 2021 Feb 1;20(2):160-166. doi: 10.1177/1474515120951981.
PMID: 33611341BACKGROUNDHolloway C, Pathare N, Huta J, Grady D, Landry A, Christie C, Pierce P, Bopp C. The Impact of a Less Restrictive Poststernotomy Activity Protocol Compared With Standard Sternal Precautions in Patients Following Cardiac Surgery. Phys Ther. 2020 Jul 19;100(7):1074-1083. doi: 10.1093/ptj/pzaa067.
PMID: 32302408BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frank R. Halfwerk, MD, PhD
Medisch Spectrum Twente, Enschede, the Netherlands
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Patients will not be actively informed on their study arm, but will receive conventional or interventional rehabilitation instructions, and might be able to deduct their allocation arm. The researcher will be blinded for intervention or control group allocation.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor and Technical Medical Doctor in Cardio-Thoracic Surgery
Study Record Dates
First Submitted
October 18, 2023
First Posted
November 3, 2023
Study Start
May 21, 2024
Primary Completion
January 1, 2026
Study Completion
March 1, 2026
Last Updated
February 7, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- Protocol is expected to be submitted for publication in 2024
- Access Criteria
- Principal Investigator generally supports Open Access publishing and data sharing.
It is not yet known if there will be a plan to make individual participant data (IPD) available. Study protocol and statistical analysis plan might be published.